12.2703.54% ( -0.450 )
Closed: Oct 6, 16:00:00 (EDT)Current ValuationThe current P/E ratio is -2.67, within the reasonable range, cheaper than 69.38% of the time in the past 5 years, and the industry ranks 25/39, the industry Median -0.85.
-2.67xP/E
$12.27Stock price
$-4.59Earnings per share
-2.67xP/E
Stock price$12.27Earnings per share$-4.59
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -0.91x
- Typical range
- -4.05x–-0.52x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
012243648
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
HTFLUSHeartFlow | -37.24x | 74.43% | $4.41B |
SDGRUSSchrodinger | -39.79x | 13.66% | $2.16B |
CERTUSCertara | -20.67x | 1,962.60% | $1.41B |
TDOCUSTeladoc | -5.91x | 22.88% | $1.05B |
MDRXUSVeradigm | -- | -- | $851.43M |
SOPHUSSophia Genetics SA | -7.77x | 19.83% | $628.24M |
EVHUSEvolent Health | -0.85x | 84.41% | $434.15M |
CTEVUSClaritev | -1.44x | 12.62% | $408.26M |
AMWLUSAmerican Well | -2.67x | 57.74% | $208.70M |
DHUSDefinitive Healthcare | -0.85x | 28.60% | $143.10M |
HCATUSHealth Catalyst | -0.50x | 4.22% | $133.20M |
LFMDUSLifeMD | -45.29x | 195.82% | $131.59M |
DRIOUSDarioHealth | -8.43x | 62.43% | $58.96M |
RNLXYUSRENALYTIX PLC SPON ADS EACH REP 50 ORD (POST SPLIT) | -2.26x | -- | $44.93M |
ITOCUSiTonic | -3.37x | -- | $30.07M |
ONMDUSOneMedNet | -3.50x | -- | $29.47M |
AIFFUSFirefly Neuroscience | -2.08x | -- | $19.61M |
BFRGUSBullfrog AI | -2.13x | 41.27% | $12.78M |
HCTIUSHealthcare Triangle | -0.49x | 93.28% | $8.33M |
WORXUSSCWorx | -3.28x | -- | $7.73M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
